Delivery Order SPE2DB22D1106-SPE2DB25FEVE8
Award Date
6/26/25
Potential Completion Date
6/27/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML medical supplies. The contract has a firm fixed price of $5,841.15 and a period of performance through June 11, 2025. This delivery order is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The contract has a firm fixed price of $2,531.46 and a completion date of August 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these medical supplies to support the healthcare needs of military treatment facilities and other federal healthcare providers. This contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,336.46, is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive global...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a completion date of June 9, 2025. The contract has a ceiling value of $2,169.57 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $13,839.57 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a period of performance through January 31, 2025. This delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.56 contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a firm fixed price delivery order with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a ceiling value of $8,377.50 and a period of performance through July 8, 2025. This is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a specialty pharmaceutical product, with a total ceiling value of $12,222.24 and a period of performance through March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,650.56, is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The contract has an ultimate completion date of March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a delivery order worth $1,383.12 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML pharmaceutical products. The contract has a final completion date of September 24, 2024 and uses a firm fixed-price pricing structure. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...